Esophageal Squamous Cell Cancer Surveillance With Cytosponge

NACompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

February 1, 2024

Study Completion Date

May 1, 2024

Conditions
Esophageal Cancer
Interventions
DEVICE

Cytosponge cell collection device

The Cytosponge™ is a minimally-invasive sampling device consisting of a polyurethane sponge compressed in a cellophane capsule attached to a string. When swallowed, the capsule dissolves in the stomach, releasing the cell collection sponge that expands to 3 cm in diameter. Next, a nurse or qualified medical technician retrieves the sponge by pulling back on the string and retracting it through the mouth. During extraction, the rough texture on the surface of the sponge collects epithelial cells in the cardia and along the entire length of the esophagus. Cytosponge™ has excellent safety profile and is approved by the Food and Drug Administration (FDA) and the Healthcare Products Regulatory Agency (HPRA) in the UK.

Trial Locations (1)

02-781

Medical Centre for Postgraduate Education, Warsaw

All Listed Sponsors
lead

Centre of Postgraduate Medical Education

OTHER

NCT04192695 - Esophageal Squamous Cell Cancer Surveillance With Cytosponge | Biotech Hunter | Biotech Hunter